AMBEV S.A. current report, Q4 FY2020

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. reports on a Board of Directors meeting held on December 9, 2020. The filing details corporate governance actions, specifically the approval of an extraordinary balance sheet as of November 30, 2020, to facilitate the distribution of Interest on Own Capital (IOC) and the authorization of equity swap agreements.

Key Financial Metrics and Capital Actions

  • Interest on Own Capital (IOC): The Board approved an IOC distribution of R$ 0.4137 per share, resulting in a net distribution of R$ 0.3517 per share after applicable taxes.
  • Payment Dates: Payment is scheduled for December 30, 2020, subject to shareholder meeting approval. The record date is December 17, 2020 (B3) and December 21, 2020 (NYSE), with shares trading ex-IOC from December 18, 2020.
  • Equity Swap Authorization: The Board authorized equity swap agreements with a potential exposure of up to 80 million common shares (or ADRs), with a limit value of up to R$ 1.2 billion.
  • Share Capital: As of the filing, there are 4,357,143,255 outstanding shares. The Company holds 289,101 shares in treasury.
  • Financial Performance: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity for the period.

Material Changes and Strategic Actions

The primary material change is the authorization of financial instruments to manage share-based compensation costs. The equity swaps are designed to neutralize the effects of stock price oscillations on the Company's share-based payment programs. These agreements are financially settled and will not involve the physical purchase or disposal of shares. The total potential exposure, including unsettled agreements from previous approvals, may reach up to 137,014,453 common shares.

Outlook, Risks, and Management Commentary

  • Purpose of Swaps: Management intends to hedge against stock price volatility to stabilize costs associated with employee and director compensation programs.
  • Termination Clauses: Counterparties may terminate agreements if the share price depreciates by 50% or more. The Company retains the option to terminate contracts at any time at its sole discretion.
  • Financial Impact: The Board confirmed that the Company's current financial situation is compatible with these operations and that they will not affect obligations to creditors or the payment of mandatory dividends.
  • Settlement Term: Approved equity swap transactions must be settled within a maximum period of 18 months (by June 9, 2022).

Investor Verification Checklist

  • Verify the final approval of the IOC distribution at the Annual Shareholders' Meeting, as the December 30 payment is ad referendum.
  • Confirm the actual execution volume and terms of the equity swap agreements, as the filing authorizes a limit rather than a fixed transaction.
  • Monitor the Company's share price volatility, as a 50% depreciation could trigger early termination of the swap agreements by counterparties.
  • Review the full 2020 annual report (Form 20-F) for comprehensive revenue, profit, and debt metrics, as this 6-K filing does not contain them.